These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32231550)

  • 61. [An elderly case of Guillain-Barré syndrome with anti-GT1b antibodies].
    Kinboshi M; Morimoto Y; Yoshida T; Kuzume D; Yamasaki M
    Rinsho Shinkeigaku; 2019 Sep; 59(9):600-603. PubMed ID: 31474642
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-GQ1b antibody syndrome presenting as acute isolated bilateral ophthalmoplegia: Report on two patients and review of the literature.
    Guisset F; Ferreiro C; Voets S; Sellier J; Debaugnies F; Corazza F; Deconinck N; Prigogine C
    Eur J Paediatr Neurol; 2016 May; 20(3):439-43. PubMed ID: 26924168
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome.
    Moscona-Nissan A; López-Hernández JC; Seidman-Sorsby A; Cruz-Zermeño M; Navalón-Calzada A
    Cureus; 2021 Oct; 13(10):e18788. PubMed ID: 34804654
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Atypical Miller Fisher Syndrome with Anisocoria and Rapidly Fluctuating Pupillary Diameter.
    Gupta G; Liu A
    Case Rep Neurol Med; 2015; 2015():472843. PubMed ID: 26380131
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnosis, pathogenesis and treatment of Miller Fisher syndrome and related disorders: clinical significance of antiGQ1b IgG antibody.
    Kusunoki S
    Expert Rev Neurother; 2003 Jan; 3(1):133-40. PubMed ID: 19810856
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Guillain-Barré syndrome.
    Fujimura H
    Handb Clin Neurol; 2013; 115():383-402. PubMed ID: 23931791
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
    Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
    J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fisher-Pharyngeal-Cervical-Brachial Overlap Syndrome With Novel Ganglioside Antibodies.
    Pedavally S; Hernández ZM; Zeidman LA
    J Clin Neuromuscul Dis; 2018 Jun; 19(4):224-227. PubMed ID: 29794578
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acute and chronic neuropathies: new aspects of Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy, an overview and an update.
    Trojaborg W
    Electroencephalogr Clin Neurophysiol; 1998 Nov; 107(5):303-16. PubMed ID: 9872432
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The co-occurrence of serologically proven myasthenia gravis and Miller Fisher/Guillain Barré overlap syndrome: a case report.
    Lau KK; Goh KJ; Lee HC; Chan YT; Tan CT
    J Neurol Sci; 2009 Jan; 276(1-2):187-8. PubMed ID: 18804791
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reversible conduction failure in overlap of Miller Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome in the spectrum of nodo-paranodopathies.
    Gürsoy AE; Kolukısa M; Babacan-Yıldız G; Altıntaş Ö; Yaman A; Asil T
    J Clin Neurosci; 2014 Jul; 21(7):1269-71. PubMed ID: 24534627
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
    Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
    Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Miller Fisher syndrome and Guillain-Barré syndrome: dual intervention rehabilitation of a complex patient case.
    Mayer JE; McNamara CA; Mayer J
    Physiother Theory Pract; 2022 Jan; 38(1):245-254. PubMed ID: 32149554
    [No Abstract]   [Full Text] [Related]  

  • 74. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum.
    Fukami Y; Wong AH; Funakoshi K; Safri AY; Shahrizaila N; Yuki N
    Eur J Neurol; 2016 Feb; 23(2):320-6. PubMed ID: 26176883
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Guillain-Barré syndrome.
    Hughes RA; Cornblath DR
    Lancet; 2005 Nov; 366(9497):1653-66. PubMed ID: 16271648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Progressive subacute Miller-Fisher syndrome successfully treated with plasmapheresis.
    Ejma M; Waliszewska-Prosół M; Hofman A; Budrewicz S; Podemski R; Bilińska M; Koszewicz M
    Neurol Neurochir Pol; 2015; 49(2):137-8. PubMed ID: 25890931
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Guillain-Barré/Miller Fisher overlap syndrome in a patient after coronavirus disease-2019 infection: a case report.
    Mohammadi SM; Abdi R; Karimi Z; Mortazavi F
    J Med Case Rep; 2022 Feb; 16(1):63. PubMed ID: 35135595
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-GQ1b-negative Miller Fisher syndrome after Campylobacter jejuni enteritis.
    Lee KY
    Pediatr Neurol; 2012 Sep; 47(3):213-5. PubMed ID: 22883289
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acute ophthalmoplegia with pupillary areflexia associated with anti-GQ1b antibody.
    Chan YC; Wilder-Smith E; Chee MW
    J Clin Neurosci; 2004 Aug; 11(6):658-60. PubMed ID: 15261245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.